Publications and communications of Julien Hanson

Caruso, M., Mazzatenta, D., Asioli, S., Costanza, G., Trivellin, G., Franke, M., Abboud, D., Hanson, J., Veronique Raverot, Pétrossians, P., Beckers, A., Cappa, M., & Daly, A. (2024). Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism. Frontiers in Endocrinology, 1-9. doi:10.3389/fendo.2024.1345363

Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Abbracchio, M. P., Abraham, G., Agoulnik, A., Alexander, W., Al-Hosaini, K., Bäck, M., Baker, J. G., Barnes, N. M., ... Ye, R. D. (October 2023). The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. British Journal of Pharmacology, 180 Suppl 2 (S2), 23 - S144. doi:10.1111/bph.16177

Schebb, N. H., Kühn, H., Kahnt, A. S., Rund, K. M., O'Donnell, V. B., Flamand, N., Peters-Golden, M., Jakobsson, P.-J., Weylandt, K. H., Rohwer, N., Murphy, R. C., Geisslinger, G., FitzGerald, G. A., Hanson, J., Dahlgren, C., Alnouri, M. W., Offermanns, S., & Steinhilber, D. (02 March 2022). Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far? Frontiers in Pharmacology, 13 (838782), 1-22. doi:10.3389/fphar.2022.838782

D'Uonnolo, G., Reynders, N., Meyrath, M., Abboud, D., Uchański, T., Laeremans, T., Volkman, B. F., Janji, B., Hanson, J., Szpakowska, M., & Chevigné, A. (2022). The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B. Frontiers in Immunology, 13, 868579. doi:10.3389/fimmu.2022.868579

Dam, J., Hanson, J., & Szpakowska, M. (2022). Editorial: Emerging receptors as new targets in health and disease. Frontiers in Endocrinology, 13, 1073794. doi:10.3389/fendo.2022.1073794

Ferraiolo, M., Beckers, P., Marquet, N., Roumain, M., Ruiz, L., Dupuis, N., Hanson, J., & Hermans, E. (February 2021). β-arrestin2 recruitment at the β2 adrenergic receptor: a luciferase complementation assay adapted for undergraduate training in pharmacology. Pharmacology Research and Perspectives, 9 (1). doi:10.1002/prp2.706

Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Melmed, S., Michel, M. C., Miller, L. J., Mitolo, V., Mouillac, B., Müller, C. E., Murphy, P., Nahon, J.-L., ... McArdle, C. A. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors. British Journal of Pharmacology, 178 Suppl 1, 27-S156. doi:10.1111/bph.15538

Abboud, D., Daly, A., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., Ectors, F., Plenevaux, A., Pirotte, B., Beckers, A., & Hanson, J. (21 September 2020). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11. Nature Communications, 11 (1), 4752. doi:10.1038/s41467-020-18500-x

Hanson, J. (2020). Nouvelles cibles et perspectives thérapeutiques. Vers une médecine de précision. Revue Médicale de Liège, 75 (5-6), 460-465.

Alexander, Christopoulos, A., Davenport, A., Kelly, E., Mathie, A., Peters, J., Veale, E., Armstrong, J., Faccenda, E., Harding, S., Pawson, A., Sharman, J., Southan, C., Davies, J., Hanson, J., & CGTP Collaborators. (December 2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology, 176 (Suppl 1), 21-S141. doi:10.1111/bph.14748

Balthazart, J., Blanpain, C., Bureau, F., Cani, P., Chariot, A., Drion, P., Engel, V., Hanson, J., de Kerchove d'Exaerde, A., Malgrange, B., Muraille, E., Nguyen, L., Servais, O., Seutin, V., & Tissir, F. (2019). L’expérimentation animale : toujours une nécessité pour la santé animale et humaine. Le Soir.

Reynders, N., Abboud, D., Baragli, A., Noman, M. Z., Rogister, B., Niclou, S., Heveker, N., Janji, B., Hanson, J., Szpakowska, M., & Chevigné, A. (18 June 2019). The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment. Cells, 8 (6).

Laschet, C., Dupuis, N., & Hanson, J. (15 March 2019). A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions. Journal of Biological Chemistry, 294 (11), 4079-4090. doi:10.1074/jbc.RA118.006231

Bakker, J., Balthazart, J., Baron, F., Beguin, Y., Bettendorff, L., Blanpain, C., Bureau, F., Caers, J., Cani, P., Cataldo, D., Cornil, C., Clercx, C., Cloots, R., Colige, A., Daube, G., De Backer, O., de Kerchove d'Exaerde, A., Desmecht, D., Desmet, C., ... Wittamer, V. (2018). La souris, le patient, et le faux expert. Décryptage d'une mystification. Le Vif. L'Express.

Muraille, E., de Kerchove d'Exaerde, A., Blanpain, C., Vassart, G., Parmentier, M., Moser, M., Oberdan, L., Vanderhaegen, P., Vanduffel, W., Vogels, R., Tissir, F., Bureau, F., Hanson, J., Drion, P., Georges, M., Seutin, V., Ris, L., & De Backer, O. (2018). L'expérimentation animale ne se fait pas en dehors de tout contrôle (OPINION). La Libre Belgique.

Alexander, S., Kelly, E., Marrion, N., Peters, J., Faccenda, E., Harding SD, Pawson, A., Sharman, J., Southan, C., Buneman, O., Cidlowski, J., Christopoulos, A., Davenport, A., Fabbro, D., Spedding, M., Striessing, J., Davies, J., Hanson, J., & CGTP Collaborators. (December 2017). THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview. British Journal of Pharmacology, 174 (Suppl 1), 1-S16. doi:10.1111/bph.13882

Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., ... Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique.

Abboud, D., Daly, A., Dupuis, N., Laschet, C., Geubelle, P., Pirotte, B., BECKERS, A., & Hanson, J. (May 2017). GPR101 orphan GPCR: a novel cause of growth hormone deregulation [Poster presentation]. 19th European Congress of Endocrinology, Lisbon, Portugal.

Drapier, T., Geubelle, P., Bouckaert, C., Goffin, E., Dilly, S., Hanson, J., Pochet, L., Kastrup, J. S., Francotte, P., & Pirotte, B. (26 May 2016). DESIGN OF HIGH-AFFINITY LIGANDS FOR THE BENZOTHIADIAZINE ALLOSTERIC BINDING SITE OF THE AMPA RECEPTORS [Poster presentation]. JFB 2016 : 30èmes Journées Franco-Belges de Pharmacochimie 25-27 May 2016 Amboise (France), Amboise, France.

Hanson, J. (18 April 2016). A forskolin free method for measuring cAMP modulation by Gi coupled receptors [Paper presentation]. Discover Glo Tour.

Gilissen, J., Jouret, F., Pirotte, B., & Hanson, J. (2016). Insight into SUCNR1 (GPR91) structure and function. Pharmacology and Therapeutics. doi:10.1016/j.pharmthera.2016.01.008

Hanson, J. (10 June 2011). Mechanism of Nicotinic acid-induced Flushing [Paper presentation]. GPCR Workshop, Utrecht, Netherlands.

Hanson, J., Gille, A., Zwykiel, S., Lukasova, M., Clausen, B., Ahmed, K., Tunaru, S., Wirth, A., & Offermanns, S. (17 July 2010). Role of Keratinocytes GPR109A and COX-2 in Nicotinic Acid and Mono-methyl Fumarate Induced Flushing [Poster presentation]. 16th World Congress of Basic and Clinical Pharmacology, Copenhagen, Denmark.

Hanson, J. (2007). Design, synthesis and pharmacological evaluation of sulfonylureas and sulfonycyanoguanidines as thromboxane A2 receptor antagonists. Insights into selectivity between thromboxane A2 receptor isoforms (TPα et TPβ) [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/77285

Lanoye, L., Segers, P., Tchana-Sato, V., Rolin, S., Dogné, J.-M., Ghuysen, A., Lambermont, B., Hanson, J., Desaive, T., Verdonck, P., D'Orio, V., & Kolh, P. (01 January 2007). Cardiovascular haemodynamics and ventriculo-arterial coupling in an acute pig model of coronary ischaemia-reperfusion. Experimental Physiology, 92 (1), 127-137. doi:10.1113/expphysiol.2006.034983

Hanson, J., Ghiotto, J., Neven, P., Kelley, L. P., Kinsella, B. T., Dogne, J. M., & Pirotte, B. (July 2006). Pharmacological evaluation of TP receptor antagonists characterized by differential activity on alpha and beta isoforms. Acta Pharmacologica Sinica, 27, 21.

Kolh, P., Rolin, S., Tchana-Sato, V., Petein, M., Ghuysen, A., Lambermont, B., Hanson, J., Magis, D., Segers, P., Masereel, B., D'Orio, V., & Dogné, J.-M. (March 2006). Evaluation of BM-573, a novel TXA(2) synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion. Prostaglandins and Other Lipid Mediators, 79 (1-2), 53-73. doi:10.1016/j.prostaglandins.2005.10.002

Tchana-Sato, V., Dogné, J.-M., Lambermont, B., Ghuysen, A., Magis, D., Morimont, P., Hanson, J., D'Orio, V., Limet, R., & Kolh, P. (December 2005). Effects of BM-573, a thromboxane A(2) modulator on systemic hemodynamics perturbations induced by U-46619 in the pig. Prostaglandins and Other Lipid Mediators, 78 (1-4), 82-95. doi:10.1016/j.prostaglandins.2005.04.001

Dogné, J.-M., Rolin, S., Tchana-Sato, V., Petein, M., Lambermont, B., Ghuysen, A., Hanson, J., & Kolh, P. (September 2005). Characterisation of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig. European Heart Journal, 26 (Suppl. 1), 455-456.

Dogné, J.-M., Rolin, S., Petein, M., Tchana-Sato, V., Ghuysen, A., Lambermont, B., Hanson, J., Magis, D., Segers, P., Pirotte, B., Masereel, B., Drion, P., D'Orio, V., & Kolh, P. (2005). Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig. Thrombosis Research, 116 (5), 431-442. doi:10.1016/j.thromres.2005.02.006